If Gilead stock holds the 11-year breakout it should move higher.
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus ...
Gilead (GILD) wraps up $7.8B Arcellx deal, gaining anito-cel therapy. Stock tests key support at $128 with oversold RSI ...
Get the live share price of Gilead Sciences Inc (GILD), including intraday charts, historical performance, key financials, ...
Zacks Investment Research on MSN
Gilead Sciences, Inc. (GILD) is a trending stock: Facts to know before betting on it
Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...
In April 2026, Arcus Biosciences said Gilead Sciences chose not to make a continuation payment, ending option rights to ...
Investors in Gilead Sciences Inc (Symbol: GILD) saw new options become available today, for the January 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...
Investors in Gilead Sciences Inc (Symbol: GILD) saw new options become available this week, for the August 2026 expiration. One of the key data points that goes into the price an option buyer is ...
Check out the latest Gilead Sciences Inc. (GILD) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results